Guidelines for Metals and Metalloids in Ambient ... - ARCHIVE: Defra

Glossary
Acute toxicity /
effects
Adenoma
Adenosine
diphosphate (ADP)
Adenosine
triphosphate (ATP)
Antioxidant
Anthropogenic
Atherosclerosis
Best Available
Technique (BAT)
Berylliosis or
chronic beryllium
disease (CBD)
Adverse effects occurring within a short time after
receiving a single dose of a chemical or
immediately following short or continuous
exposure, or multiple doses over 24 hours or less.
A benign tumour with the structure or appearance
of a gland or originating in a gland.
Formed following hydrolysis of adenosine
triphosphate (ATP).
A nucleotide that is of fundamental importance as
a carrier of chemical energy in all living
organisms.
A substance that inhibits oxidation and can guard
the body from the damaging effects of free radicals.
Man-made.
A disease affecting arterial blood vessels. It is a
chronic inflammatory response in the walls of
arteries, commonly referred to as a ‘hardening’ or
‘furring’ of the arteries.
The most effective and advanced technique for
the prevention, or where that is not practicable,
the minimisation of emissions and impact on the
environment as a whole, taking into account the
availability of the technique for the type of
process concerned and cost.
An occupational lung disease arising from an
allergic-type response to beryllium and its
compounds in the workplace. The condition is
characterised by lung scarring and is incurable,
treatment being symptomatic only.
109